David Urech (file photo)
Mitsubishi joins Eisai, 3SBio's bet on multispecific antibodies, upping Numab's Series B haul to $23M+
Following a busy year of dealmaking, Swiss antibody shop Numab has closed a Series B at CHF22 million ($23.87 million) to double down on its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
